Algorithmiq, a Helsinki-based quantum software company, has become the sole winner of a €1.7 million ($2 million) prize from Wellcome…
Read More
STORM Therapeutics raises €47.5 million Series C to harness the power of RNA modification to treat cancer
STORM Therapeutics (STORM), a Cambridge-based BioTech company tarreceiveing RNA modifications to reprogram cells and develop novel cancer therapies, today announced…
Read More
Do All Patients in Europe Have Equal Acess to Cancer Clinical Trials? – ESMO
European Society for Medical Oncology (ESMO), shared a post on LinkedIn: “Do all patients in Europe have equal access to…
Read More
Gustavo Monnerat: New Lancet Regional Health Europe Series on Where Cancer Therapy May Be Heading
Gustavo Monnerat, Deputy Editor at The Lancet, shared a post on LinkedIn: “A new Lancet Regional Health – Europe series…
Read More
Utrecht’s Laigo Bio completes final close of €17 million Seed round to advance cancer and autoimmune therapies
Laigo Bio, a Utrecht-based BioTech firm focapplyd on protein degradation for tarreceiveed therapies, has concluded the second close of its…
Read More
Local police officer raising money to fight cancer
Lieutenant Angela McGovern from the Saratoga Springs Police Department is in pursuit of a cure with Blood Cancer United. She…
Read More
From cancer tests to COVID vaccines: the women reshaping Europe’s health in a male-dominated field
When considering about female inventors, the most common name to come to mind is probably Marie Curie. ADVERTISEMENT ADVERTISEMENT For…
Read More
Rowers raising funds for people affected by cancer
Teams of rowers are set to take part in an indoor challenge to raise money for charity. Macmillan Cancer Support…
Read More
Incyte’s Drug Approved In Europe For Treating Yet Another Rare Cancer
The company declared that EC approved Zynyz in combination with carboplatin and paclitaxel for adult patients with metastatic or with…
Read More
Cancer medtech tops up Series B to $28 million
Sydney cancer medtech startup Lumonus, has added an additional $3 million to its Series B, four months on, to take…
Read More
